WASHINGTON UNIVERSITY ST. LOUIS;Eli Lilly & Company
发明人:
Holtzman, David, M.,Demattos, Ronald,Bales, Kelly, R.,Paul, Steven, M.,Tsurushita, Naoya,Vasquez, Maximiliano
申请号：
DK04011466
公开号：
DK1481992T3
申请日:
2001.02.26
申请国别(地区):
DK
年份:
2017
代理人:
摘要：
A method to treat conditions characterized by formation of amyloid plaques both prophylactically and therapeutically is described. The method employs humanized antibodies which sequester soluble A beta peptide from human biological fluids or which preferably specifically bind an epitope contained within position 13-28 of the amyloid beta peptide A beta . <；IMAGE>；
